골다공증에서 알렌드로네이트 투여 시 에스트로젠 용량에 따른 치료 효과

참고문헌 (33)

1. "폐경 및 호르몬 대체요법 기간에 따른 골밀도,골대사 표지자,지질의 변화", 25, pp.491~497 (2001)
2. "폐경기간에 따른 혈중 Estradiol과 Lipid Profile 골대사 표지자 및 골밀도와의 연관 관계", 24, pp.318~325 (2000)
3. "폐경 후 골다공증 환자에서 지속적 호르몬 대체요법과 알렌드로네이트 병합치료", 26, pp.208~214 (2002)
4. "Effect of lower doses of conjugated equine estrogens and medroxyprogesterone acetate on endometrial bleeding", 75, pp.1080~1087 (2001)
5. "Estrogen and coronary heart disease in women", 265, pp.1861~1867 (1991)
6. "Alendronate daily, weekly in conventional tablets and weekly in enteric tablets preliminary study of the effects in bone turnover makers and incidence of side effects", 23, pp.278~281 (2003)
7. "Alendronate and estrogen effects in postmenopausal women with low bone mineral density", 85, pp.720~726 (2000)
8. "Protein synthesis in required for caspase activation and induction of apoptosis by bisphophonate drugs", 54, pp.631~638 (1998)
9. "Postmenopausal osteoporosis", 353, pp.1974~1975 (2005)
10. "Alendronate treatment of the postmenopausal osteoporotic woman effect of multiple dosages on bone mass and bone remodeling", 99, pp.144~152 (1995)
11. "Low-dose estrogen therapy for menopausal women:a review of efficacy and safety", 12, pp.723~747 (2003)
12. "Serum bone Gla-protein compared to bone histomorphometry in endocrine disease", 6, pp.339~341 (1985)
13. "Treatment of postmenopausal osteoporosis", 338, pp.736~746 (1998)
14. "Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium", 106, pp.40~45 (1987)
15. "Effects of alendronate and hormone replacement therapy,alone and in combination,on bone mass and markers of bone turnover in elderly women with osteoporosis", 89, pp.626~631 (2004)
16. "Effect of progestin therapy on cortical and trabecular bone:comparsion with estrogen", 90, pp.171~178 (1991)
17. "Effects of low dose continuous combined conjugated estrogens and medroxy-progesterone acetate on menopausal symptoms and metabolism in posmenopausal wonen", 185, pp.1180~1185 (2001)
18. "Postmenopausal femur bone loss:effects of a low dose hormone replacement therapy", 25, pp.175~183 (2003)
19. "Cytokines, bone remodeling and estrogen deficiency: a 1998 update.", 23, pp.75~81 (1998)
20. "Clinical usefulness of biochemical resorption markers in osteoporosis", 36, pp.483~491 (1999)
21. "The rationale for low-dose hormonal therapy", 24, pp.217~221 (2004)
22. "Effects of low doses of conjugated equine estrogens and medroxyprogesterone acetate on plasma lipid and lipoproteins,coagulation factors,and carbohydronate metabolism", 76, pp.13~24 (2001)
23. "Heterocycle-containing bisphosphonate cause apoptosis and inhibit bone resorption by preventing protein prenylation:evidence from structure-activity relationship in J774 macrophages", 13, pp.1668~1678 (1998)
24. "Fracture protection provided by long-term estrogen treatment", 5, pp.23~29 (1995)
25. "Urinary excertion of pyridinium crosslinks of collagen in patients with osteoporosis and the effects of bone fracture", 51, pp.648~651 (1992)
26. "Hormone replacement therapy and risk of hip fracture:population based case-control study", 316, pp.1853~1863 (1998)
27. "Prevention of postmenopausal bone loss with minimal uterine bleeding using low dose continuous estrogen", progestin therapy:a 2-year prospective study, 1997, pp.27, 69~76
28. "The effect of low-dose continuous estrogen and progesterone therapy with calcium and vitamin D on bone in elderly women. A randomized, controlled trial.", 130, pp.897~904 (1999)
29. "Skeletal benefits of alendronate: 7-year treatment of postmenopausal osteoporotic women. Phase III Osteoporosis Treatment Study Group", 85, pp.3109~3115 (2000)
30. "Effects of hormone replacement therapy on bone mineral density:results from the Postmenopausal Estrogen", Prosgestin interventions trial, 1996, pp.276, 1389~1396
31. "Risk and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the women's health initiative randomised controlled trial.", 228, pp.321~333 (2000)
32. "Hormone replacement therapy in postmenopausal women", 3, pp.136~145 (2003)
33. "Does postmenopausal estrogen administration increase the risk of breast cancer Contributions of animal and clinical investigative studies to a resolution of the controversy", 217, pp.30~37 (1998)

관련 논문AI추천